ATE8140T1 - 2-(4-(diphenylmethyl)-1-piperazinyl)-essigsaeure und ihre amide, verfahren zu ihrer bereitung und pharmazeutische zusammensetzungen. - Google Patents

2-(4-(diphenylmethyl)-1-piperazinyl)-essigsaeure und ihre amide, verfahren zu ihrer bereitung und pharmazeutische zusammensetzungen.

Info

Publication number
ATE8140T1
ATE8140T1 AT82870006T AT82870006T ATE8140T1 AT E8140 T1 ATE8140 T1 AT E8140T1 AT 82870006 T AT82870006 T AT 82870006T AT 82870006 T AT82870006 T AT 82870006T AT E8140 T1 ATE8140 T1 AT E8140T1
Authority
AT
Austria
Prior art keywords
diphenylmethyl
piperazinyl
amides
processes
preparation
Prior art date
Application number
AT82870006T
Other languages
German (de)
English (en)
Inventor
Eugene Baltes
Jean De Lannoy
Ludovic Rodriguez
Original Assignee
U C B, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U C B, S.A. filed Critical U C B, S.A.
Application granted granted Critical
Publication of ATE8140T1 publication Critical patent/ATE8140T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT82870006T 1981-02-06 1982-02-05 2-(4-(diphenylmethyl)-1-piperazinyl)-essigsaeure und ihre amide, verfahren zu ihrer bereitung und pharmazeutische zusammensetzungen. ATE8140T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8103768 1981-02-06
GB8110990 1981-04-08
EP82870006A EP0058146B1 (fr) 1981-02-06 1982-02-05 Nouveaux acides 2-(4-(diphénylméthyl)-1-pipérazinyl)-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques

Publications (1)

Publication Number Publication Date
ATE8140T1 true ATE8140T1 (de) 1984-07-15

Family

ID=26278356

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82870006T ATE8140T1 (de) 1981-02-06 1982-02-05 2-(4-(diphenylmethyl)-1-piperazinyl)-essigsaeure und ihre amide, verfahren zu ihrer bereitung und pharmazeutische zusammensetzungen.

Country Status (24)

Country Link
US (1) US4525358A (forum.php)
EP (1) EP0058146B1 (forum.php)
AT (1) ATE8140T1 (forum.php)
AU (1) AU544066B2 (forum.php)
BA (2) BA97198B1 (forum.php)
CA (1) CA1199918A (forum.php)
CY (1) CY1307A (forum.php)
DE (2) DE10199021I2 (forum.php)
DK (2) DK154078C (forum.php)
ES (2) ES8307776A1 (forum.php)
FI (1) FI75816C (forum.php)
GE (1) GEP20001996B (forum.php)
GR (1) GR75407B (forum.php)
HK (1) HK86485A (forum.php)
HU (1) HU184989B (forum.php)
LU (1) LU90870I2 (forum.php)
MY (1) MY8700279A (forum.php)
NL (1) NL300074I2 (forum.php)
NO (2) NO155805C (forum.php)
NZ (1) NZ199650A (forum.php)
PL (2) PL134903B1 (forum.php)
PT (1) PT74390B (forum.php)
SU (2) SU1227113A3 (forum.php)
YU (2) YU43511B (forum.php)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983001950A1 (en) * 1981-12-02 1983-06-09 BJÖRK, Anders, Karl, Konrad 1-piperazinocarboxylates, process for their preparation and pharmaceutical compositions containing them
JPS59118765A (ja) * 1982-12-24 1984-07-09 Fujisawa Pharmaceut Co Ltd ピペラジン誘導体
GB8320701D0 (en) * 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5831066A (en) 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
US5057524A (en) * 1990-02-08 1991-10-15 A. H. Robins Company Incorporated 4-[diaryl)hydroxymethyl]-1-piperidinealkylcarboxylic acids, salts and esters useful in the treatment of allergic disorders
FR2665160A1 (fr) * 1990-07-26 1992-01-31 Esteve Labor Dr Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments.
EP0663828B1 (en) * 1992-09-24 1998-09-09 Sepracor, Inc. Treating allergic rhinitis and asthma using (-) Cetirizine
JPH08501562A (ja) * 1992-09-24 1996-02-20 セプラコア，インコーポレイテッド 光学的に純粋な（＋）セチリジンを用いたアレルギー疾患の治療のための方法および組成
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
JP3338913B2 (ja) * 1993-06-29 2002-10-28 大鵬薬品工業株式会社 テトラゾール誘導体
MY111348A (en) * 1993-07-30 1999-11-30 Ardent Pharmaceuticals Inc Opioid diarylmethylpiperazines and piperidines
US5859295A (en) * 1994-12-05 1999-01-12 University Of Kentucky Research Foundation Canavanine analogs and their use as chemotherapeutic agents
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
CA2180190A1 (en) * 1995-07-10 1997-01-11 Kazumi Ogata Benzylpiperazine derivatives
US6469009B1 (en) * 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
BE1010094A3 (fr) 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.
CA2180993A1 (en) * 1996-07-11 1998-01-12 Yong Tao Methods for the manufacture of cetirizine
PE107598A1 (es) * 1996-09-11 1999-01-29 Ucb Sa Cetirizina util para el tratamiento de enfermedades de tipo virico
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP0919550A1 (en) 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
US6660301B1 (en) 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
CN1714783A (zh) 1998-03-06 2006-01-04 生物领域医疗公司 用于组织膨胀和治疗的可植入颗粒
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
IL124195A (en) * 1998-04-23 2000-08-31 Chemagis Ltd Process for the preparation of esters of 2-¬4-¬4-chlorophenyl¾phenylmethyl¾-1-piperazinyl¬ethoxy¾acetic acid
WO2000004900A1 (en) 1998-07-20 2000-02-03 Bristol-Myers Squibb Company Substituted benzimidazole antiviral agents
US6432961B1 (en) 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
DK176706B1 (da) * 1999-03-04 2009-03-30 Sandoz As Fremgangsmåde til fremstilling af 2-{2-[4-(diphenylmethyl)-1-piperazinyl]ethoxy}-eddikesyre-forbindelser eller salte deraf
PE20001566A1 (es) * 1999-03-26 2001-02-05 Ucb Sa Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas
US6686502B1 (en) 1999-03-26 2004-02-03 Ucb S.A. Compounds and methods for treatment of asthma, allergy and inflammatory disorders
US6894059B1 (en) 1999-03-26 2005-05-17 Ucb S.A. Compounds and methods for treatment of asthma, allergy and inflammatory disorders
GR990100135A (el) * 1999-04-22 2000-12-29 Genepharm �.�. Μεθοδος παρασκευης του 2-(2-[4-[4-χλωροφαινυλο)(φαινυλο)μεθυλο]πιπεραζινο]αιθοξυ) οξικου οξεος και του διυδροχλωρικου αλατος αυτου
CA2376781A1 (en) 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
US6267986B1 (en) 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US6239277B1 (en) * 1999-10-20 2001-05-29 Salsbury Chemicals, Inc. Process for preparing piperazine-substituted aliphatic carboxylates
US6265579B1 (en) * 1999-10-29 2001-07-24 Salsbury Chemicals, Inc. Process for preparing piperazine-substituted aliphatic carboxylates
HRP20020470B1 (hr) * 1999-11-30 2009-04-30 Egis Gy�gyszergy�r RT POSTUPAK PRIREĐIVANJA {2-[4-(α-FENIL-p-KLORBENZIL)-PIPERAZIN-1-IL]ETOKSI} OCTENE KISELINE I NOVIH INTERMEDIJERA
US7338657B2 (en) * 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
US6436424B1 (en) * 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
EP1274472A2 (en) 2000-03-20 2003-01-15 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
US6489338B2 (en) 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6774134B2 (en) 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
US6977301B1 (en) 2001-05-29 2005-12-20 Ucb, S.A. Process for preparing (S) and (R)—2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
US7199241B1 (en) 2001-05-29 2007-04-03 Ucb, S.A. Process for preparing (S) and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
WO2002100444A1 (en) * 2001-06-08 2002-12-19 Biosphere Medical Inc. Colloidal metal labelled microparticles, their production and use
JP2005503368A (ja) * 2001-07-26 2005-02-03 ユ セ ベ ソシエテ アノニム ２−（２−（４−（ビス（４−フルオロフェニル）メチル）−ピペラジン−１−イル）エトキシ）酢酸誘導体、又は対応するその塩形態及びそのための中間体の調製方法
US6919331B2 (en) 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
MXPA04009387A (es) 2002-03-27 2005-01-25 Sun Pharmaceutical Ind Ltd Derivados de 4-(diarilmetil)-1-piperacinilo.
BR0308927A (pt) 2002-04-04 2005-01-04 Pfizer Prod Inc Comprimido mastigável de sabor agradável
AU2003238883A1 (en) * 2002-06-05 2003-12-22 Dr.Reddy's Laboratories Ltd. A novel amorphous form of (2-(4-((4-chlorophenyl)-phenyl methyl)-1- piperazinyl) ethoxy) acetic acid dihydrochloride (cetirizine dihydrochloride)
US20040186112A1 (en) * 2002-12-04 2004-09-23 Dr. Reddy's Laboratories Limited Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof
US20050020608A1 (en) * 2003-03-25 2005-01-27 Dr. Reddy's Laboratories Limited Crystalline cetirizine monohydrochloride
US20060258684A1 (en) * 2003-05-21 2006-11-16 Singh Prasad S 2-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl]ethoxy]acetic acid monohydrochloride as anti-allergenic compound and process for its production
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
KR100503443B1 (ko) * 2004-02-02 2005-07-22 한림제약(주) 광학적으로 활성인 세티리진 또는 그의 염의 제조방법
KR100698400B1 (ko) * 2004-04-14 2007-03-23 이은주 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
AU2005232511B2 (en) * 2004-04-14 2008-07-03 Eun-Joo Lee Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia
PE20060484A1 (es) 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
US20060127479A1 (en) * 2004-10-08 2006-06-15 Natrajan Kumaraperumal Solvent free taste masked pharmaceutical compositions
WO2006050909A1 (en) * 2004-11-10 2006-05-18 Ucb Farchim Sa Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them
WO2007004236A2 (en) 2005-07-04 2007-01-11 Ramu Krishnan Improved drug or pharmaceutical compounds and a preparation thereof
HU227325B1 (en) * 2005-12-08 2011-03-28 Egis Gyogyszergyar Nyrt Process for the production of an intermediate of (dextro- and levo)- cetirizine
NZ573174A (en) 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
NZ573173A (en) 2006-06-01 2012-03-30 Msd Consumer Care Inc Phenylephrine pharmaceutical formulation and compositions for colonic absorption
EP2041088B1 (en) * 2006-06-28 2014-01-08 Amgen Inc. Glycine transporter-1 inhibitors
KR100913850B1 (ko) * 2006-12-29 2009-08-26 우석대학교 산학협력단 고소하고 풍부한 버터향을 가지며 트랜스 지방산 함량이 낮은 가공 식용유의 제조방법 및 이 방법에 의해 제조된 가공 식용유
CA2679070C (en) 2007-03-12 2016-04-26 Nektar Therapeutics Oligomer-antihistamine conjugates
WO2009057133A2 (en) * 2007-07-24 2009-05-07 Glenmark Generics Limited A process for the synthesis of 2-[2-[4-[(4-chlorophenyl)phenyl methyl]-1-piperazinyl] ethoxy acetic acid
EP2175856A4 (en) * 2007-08-15 2011-08-24 Chemagis Ltd NOVEL PROCESS FOR THE PREPARATION OF HIGH-PURITY LEVOCETRIXIN AND ITS SALTS
US20090062305A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched cetirizine
WO2009062036A2 (en) * 2007-11-09 2009-05-14 Dr. Reddy's Laboratories Ltd. Processes for preparing levocetirizine and pharmaceutically acceptable salts thereof
US7989623B2 (en) 2007-11-21 2011-08-02 Synthon Bv Process for making n-(diphenylmethyl)piperazines
ES2361343T3 (es) 2007-11-21 2011-06-16 Synthon B.V. Procedimiento para obtener n-(difenilmetil)piperazinas.
US20090281156A1 (en) * 2007-12-21 2009-11-12 Schering-Plough Healthcare Products, Inc, Enhancing photostabilization of oxymetazoline
KR20110022635A (ko) * 2008-06-02 2011-03-07 시플라 리미티드 레보세티리진의 합성방법 및 이에 사용하기 위한 중간체
US20110172425A1 (en) * 2008-09-17 2011-07-14 Calyx Chemicals And Pharmaceuticals Pvt. Ltd. Novel water based process for the preparation of substituted diphenylmethyl piperazines
US20100145049A1 (en) * 2008-11-21 2010-06-10 Jie Zhu Process for making n-(diphenylmethyl)piperazines
WO2010107404A1 (en) 2009-03-16 2010-09-23 Mahmut Bilgic Stable pharmaceutical combinations
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
JP6033677B2 (ja) 2009-03-17 2016-11-30 ナイコックス オフサルミクス， インコーポレイテッド セチリジンの眼科用製剤および使用方法
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
WO2011110939A2 (en) 2010-03-11 2011-09-15 Rubicon Research Private Limited Pharmaceutical compositions of substituted benzhydrylpiperazines
WO2011146032A2 (en) 2010-05-18 2011-11-24 Mahmut Bilgic Effervescent formulations
CN101928263A (zh) * 2010-07-06 2010-12-29 四川大学 一种制备盐酸乙氟利嗪的方法
TR201007652A2 (tr) 2010-09-20 2012-04-24 Bi̇lgi̇ç Mahmut Sinerjik etki.
TR201009398A2 (tr) 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Fiziksel özellikleri geliştirilmiş tablet formülasyonları
JP5362151B2 (ja) 2011-09-29 2013-12-11 塩野義製薬株式会社 Ｐｇｄ２拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬
KR101418404B1 (ko) 2012-01-06 2014-07-10 한미약품 주식회사 레보세티리진 또는 이의 약학적으로 허용가능한 염 및 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 함유하는 안정한 경구투여용 약학 제제
KR102226833B1 (ko) 2013-06-28 2021-03-12 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성이 개선된 복합 과립 제형
CN103508879B (zh) * 2013-09-22 2015-10-21 江苏德峰药业有限公司 一种卤代烷氧基乙酸的合成方法
US20170001988A1 (en) * 2013-11-27 2017-01-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Piperidine and piperazine derivatives and their use in treating viral infections and cancer
EP3081569B1 (en) 2013-12-10 2019-09-18 Shandong Danhong Pharmaceutical Co., Ltd. Imidazole derivative used as antiviral agent and use thereof in preparation of medicament
US10227309B2 (en) 2015-06-08 2019-03-12 Shandong Danhong Pharmaceutical Co., Ltd. Crystal form A of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one
AU2016342374B2 (en) 2015-10-23 2022-08-04 Lyndra Therapeutics, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
MX2018006912A (es) 2015-12-08 2018-08-16 Lyndra Inc Configuracion geometricas para sistemas de residencia gastrica.
WO2017196235A1 (en) * 2016-05-09 2017-11-16 Biogaia Ab Selection of bacterial strains useful in allergy treatment
WO2017205844A2 (en) 2016-05-27 2017-11-30 Lyndra, Inc. Materials architecture for gastric residence systems
WO2018064630A1 (en) 2016-09-30 2018-04-05 Lyndra, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
CN110996906A (zh) 2017-06-09 2020-04-10 林德拉有限公司 具有调节释放速度的膜的胃驻留系统
AU2021217209A1 (en) 2020-02-03 2022-09-29 Kenvue Brands Llc A single layer chewable tablet comprising cetirizine
WO2022106923A1 (en) 2020-11-18 2022-05-27 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound
CN113861131B (zh) * 2021-11-08 2024-04-19 深圳菲斯生物科技有限公司 一种西替利嗪杂质c的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899436A (en) * 1959-08-11 chjch
US2630435A (en) * 1948-09-09 1953-03-03 Burroughs Wellcome Co N-benzohydryl-n-methyl piperazines and process of preparing same
US2636032A (en) * 1949-04-12 1953-04-21 Abbott Lab N, n'-disubstituted piperazines and process of preparing same
US2861072A (en) * 1952-07-19 1958-11-18 Abbott Lab Preparation of piperazine derivatives
US3244718A (en) * 1964-02-17 1966-04-05 Biel John Hans Piperazine derivatives
NL137318C (forum.php) * 1964-06-09
FR2082168A5 (en) * 1970-03-05 1971-12-10 Aries Robert (-1-benzhydryl-4-piperazinyl)-alkoxy-alkyl esters of benzoic - or phenyl-alkanoic acids - analgesic, antipyretic, sympathomimetic,
FR2081579B1 (forum.php) * 1970-03-18 1973-04-06 Delalande Sa
BE794804A (fr) * 1972-02-01 1973-05-16 Crc Ricerca Chim Procede de preparation de derives de piperazine, et produits obtenus

Also Published As

Publication number Publication date
HU184989B (en) 1987-06-30
YU23782A (en) 1985-06-30
DE10199021I1 (de) 2001-06-21
GR75407B (forum.php) 1984-07-13
PT74390A (fr) 1982-03-01
FI75816B (fi) 1988-04-29
US4525358A (en) 1985-06-25
PT74390B (fr) 1983-07-05
NO2001022I2 (no) 2005-10-10
GEP20001996B (en) 2000-02-10
DK44082A (da) 1982-08-07
DK154078B (da) 1988-10-10
DK154078C (da) 1989-05-22
SU1287749A3 (ru) 1987-01-30
BA97198B1 (bs) 1999-08-02
PL239687A1 (en) 1983-07-18
YU43511B (en) 1989-08-31
CY1307A (en) 1985-12-06
DK155796C (da) 1989-10-09
PL234935A1 (en) 1983-05-09
YU42911B (en) 1988-12-31
DE10199021I2 (de) 2002-07-04
FI820318L (fi) 1982-08-07
EP0058146B1 (fr) 1984-06-27
NO820297L (no) 1982-08-09
EP0058146A1 (fr) 1982-08-18
HK86485A (en) 1985-11-15
ES509358A0 (es) 1983-08-01
LU90870I2 (en) 2002-03-01
MY8700279A (en) 1987-12-31
SU1227113A3 (ru) 1986-04-23
DK5388A (da) 1988-01-07
NO155805C (no) 1987-06-10
BA97199B1 (bs) 1999-08-02
NZ199650A (en) 1984-07-06
AU544066B2 (en) 1985-05-16
ES8307776A1 (es) 1983-08-01
DK5388D0 (da) 1988-01-07
DK155796B (da) 1989-05-16
NO155805B (no) 1987-02-23
NL300074I1 (nl) 2002-02-01
AU8023182A (en) 1982-08-12
CA1199918A (en) 1986-01-28
NL300074I2 (nl) 2002-03-01
ES8406455A1 (es) 1984-08-01
PL134903B1 (en) 1985-09-30
PL134969B1 (en) 1985-09-30
FI75816C (fi) 1988-08-08
ES521548A0 (es) 1984-08-01
YU223584A (en) 1985-06-30
DE3260282D1 (en) 1984-08-02

Similar Documents

Publication Publication Date Title
ATE8140T1 (de) 2-(4-(diphenylmethyl)-1-piperazinyl)-essigsaeure und ihre amide, verfahren zu ihrer bereitung und pharmazeutische zusammensetzungen.
ATE8388T1 (de) 2-(4-(diphenylmethylen)-1-piperidinyl)essigsaeur n und ihre amide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.